Genetic study demonstrates fat-selective weight loss with GLP-1 agonist use
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant…
Read More...
Read More...